Mechanically, we identified that disordered glycolipid metabolism aggravated TSC senescence and activated the CXCL13-CXCR5 axis in TSCs, which led to enhanced osteogenic differentiation of TSCs. The gene discussed is CXCL13; the disease is tuberous sclerosis.